-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Neutrophil-lymphocyte ratio (NLR) is a putative indicator that measures the balance between neutrophil-related pre-tumor inflammation and lymphocyte-dependent anti-tumor immune function.
It has been considered to include hepatocellular carcinoma (HCC).
), including several prognostic indicators of cancer
.
Recently, a research article was published in the British Journal of Cancer, an authoritative journal in the field of oncology.
In this study, researchers included 781 patients (493 cases of hepatocellular carcinoma and 288 cases of chronic liver disease without hepatocellular carcinoma).
The prospective cumulative cohort was followed up for more than 6 years
.
The researchers compared the NLR levels between patients with liver cancer and chronic liver disease, and assessed the impact of baseline NLR on the overall survival of patients with liver cancer through multivariate Cox regression analysis
.
Survival curve
At the beginning of the study (baseline), there was no clinically significant difference in NLR values between patients with chronic liver disease and HCC patients
.
Among HCC patients, the NLR level closest to the last visit/death was significantly higher than the baseline level
It can be seen that NLR is an important independent factor affecting the survival of HCC patients
NLR is an important independent factor affecting the survival of HCC patients
Original source:
Original source:Philip J.
The prognostic and diagnostic significance of the neutrophil -to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study in this message